1 Press release, July 3, 2026, ADOCIA Announces the Expiration of Exclusive Right to Negotiate Partnership for M1Pram with SANOFI 2 Press Release, July 5, 2023, ADOCIA Grants Sanofi an Exclusive Right to Negotiate a Partnership on M1Pram for 10 Million Euros and Obtains Commitment from Investors to Provide 10 Million Euros in Financing 3 Press Release, July 25, 2025, ADOCIA and Tonghua Dongbao Announce Positive Topline Results of Phase 3 Clinical Trial on Ultra-Rapid Insulin BioChaperone Lispro (THDB0206 injection) in people with T2D 4 Press Release, October 15, 2025, ADOCIA and Tonghua Dongbao Announce Positive Topline Results of Phase 3 Clinical Trial on Ultra-Rapid Insulin BioChaperone Lispro (THDB0206 injection) in people with T1D 5 GMP = Good Manufacturing Practices 6 P ress Release, November 12, 2025, ADOCIA Announces Filing of Patent for New Long-Acting Peptides Platform in Diabetes and Obesity - AdoXLong - and Provides an Update on its BioChaperone Platform Adocia Olivier Soula CEO [email protected] +33 (0)4 72 610 610 www.adocia.com Maarc Adocia Press & Investor Relations Bruno Arabian Yasmine Duval Thomas Rolnik [email protected] + 33 (0)6 87 88 47 26 View source version on businesswire.com: The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties

Ellong, E
Figure 3 Dissolution of semaglutide from Eudragit FL 30 D-55 coated capsules with increasing coating weight gains (see Example 27)
GHK-Cu 50MG Buy 5 for $33.24 each for a 5% discount Buy 10 for $31.49 each for a 10% discount Synonyms glycyl-l-histidyl-l-lysine, 49557-75-7, Prezatide, Glycyl-histidyl-lysine, Copper(II)ghk IUPAC Condensed H-Gly-His-Lys-OH Sequence GHK PubChem CID 73587 CAS Number 89030-95-5 Molecular Weight 340.38g/mol Molecular Formula C 14 H 24 N 6 O 4 Reference: PubChem THIS PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY